This prospective study evaluated the electroencephalographic (EEG) diagnostic and prognostic value in childhood HIV infection. It was carried out on 125 subjects and included all Piemonte's seropositive children. The EEG was repeated every three months during the first 15 months of life, and then, at least, annually in the P1 and P2 group. Data of group P2 was compared blindly to that of the seroconverted control group of the same age and risk. EEG results were normal in P0, P1 and control patients. In group P2, EEG was abnormal in 35.5% of subjects, of these 54.6% developed an encephalopathy with a delay of 2.5 months to 2 years 11 months. EEG is therefore useful to evaluate early CNS damage and to identify onset features and evolution of encephalopathy in P2 patients.

EEG diagnostic and predictive value on HIV infection in childhood. / Vigliano P; Rigardetto R; Capizzi G; Arfelli P; Barbicinti I; Boffi P; Bonassi E; Cavallo P; Crosa P; Gandione M; Genta M; Di Cagno L.. - In: NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY. - ISSN 0987-7053. - 24(5)(1994), pp. 367-379.

EEG diagnostic and predictive value on HIV infection in childhood.

RIGARDETTO, Roberto;CAPIZZI, Giorgio;BOFFI, Patrizia;GANDIONE, Marina;GENTA, Marina Maria Pia;DI CAGNO, Livia
1994

Abstract

This prospective study evaluated the electroencephalographic (EEG) diagnostic and prognostic value in childhood HIV infection. It was carried out on 125 subjects and included all Piemonte's seropositive children. The EEG was repeated every three months during the first 15 months of life, and then, at least, annually in the P1 and P2 group. Data of group P2 was compared blindly to that of the seroconverted control group of the same age and risk. EEG results were normal in P0, P1 and control patients. In group P2, EEG was abnormal in 35.5% of subjects, of these 54.6% developed an encephalopathy with a delay of 2.5 months to 2 years 11 months. EEG is therefore useful to evaluate early CNS damage and to identify onset features and evolution of encephalopathy in P2 patients.
24(5)
367
379
Vigliano P; Rigardetto R; Capizzi G; Arfelli P; Barbicinti I; Boffi P; Bonassi E; Cavallo P; Crosa P; Gandione M; Genta M; Di Cagno L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/37815
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact